Skip to main content
Clinical Trials/NCT01989247
NCT01989247CompletedNot Applicable

Self-management of Depression and Anxiety. A Randomized Controlled Trial.

University of Aarhus37 sites in 1 country853 target enrollmentStarted: June 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
853
Locations
37
Primary Endpoint
Depressive Symptoms (Beck's Depression Inventory (BDI-II))

Study Overview

Brief Summary

The purpose of this study is to investigate whether citizens experiencing symptoms of anxiety and depression will benefit from a self-management training program with respect to: 1) Self-efficacy, and 2) Symptoms of anxiety and depression, and 3) Self reported measures of Health Related Quality of Life (HRQoL)

Detailed Description

  • The intervention is a Danish adaption of The Chronic Disease Self-Management Program developed by The Stanford Patient Education Research Center, The Expert Patient Program Community Interest Company (EPPCIC), and The English National Health Service (NHS).
  • The Danish adaptation has been performed by The Danish Committee for Health Education.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •>= 18 years of age
  • •Suffering from anxiety and/or depressive symptoms
  • •Voluntary participation

Exclusion Criteria

  • •Potential suicidal behavior
  • •Potential aggressive behavior
  • •Significant cognitive impairment

Arms & Interventions

Self-management program

Experimental

Seven weekly sessions of a group-based self-management programme for people with anxiety and depressive symptoms

Intervention: Self-management programme (Behavioral)

Control group

No Intervention

Outcomes

Primary Outcomes

Depressive Symptoms (Beck's Depression Inventory (BDI-II))

Time Frame: Change from 1) Pre-randomization, to 2) Three months post-intervention

State Anxiety (Spielbergers State-Trait Anxiety Inventory (STAI))

Time Frame: Change from 1) Pre-randomization, to 2) Three months post-intervention

Only the State-anxiety subscale of the STAI is used

Self-efficacy (Chronic Disease Self-efficacy Scales - SECD-32 (Stanford Patient Education Research Center))

Time Frame: Change from 1) Pre-randomization, to 2) Three months post-intervention

Only the following subscale is used: "Obtain help from Community, Family, Friends Scale"

Self-efficacy ("Personal control" from "The Revised Illness Perception Questionnaire" (IPQ-R))

Time Frame: Change from 1) Pre-randomization, to 2) Three months post-intervention

Only the following subscale from the IPQ-R is used: "Personal Control"

Secondary Outcomes

  • Exercise Behaviors (Stanford Patient Education Research Center)(Change from 1) Pre-randomization, to 2) Three months post-intervention)
  • Health related symptoms(Change from 1) Pre-randomization, to 2) Three months post-intervention)
  • Social/Role Activities Limitations Scale (Stanford Patient Education Research Center)(Change from 1) Pre-randomization, to 2) Three months post-intervention)
  • Self-efficacy ("Control/Manage Depression Scale from: "Chronic Disease Self-efficacy Scales - SECD-32 (Stanford Patient Education Research Center))(Change from 1) Pre-randomization, to 2) Three months post-intervention)
  • Sleep Quality (The Pittsburgh Sleep Quality Index)(Change from 1) Pre-randomization, to 2) Three months post-intervention)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Søren Christensen

Senior Researcher

University of Aarhus

Study Sites (37)

Loading locations...

Similar Trials